Pharmaceuticals Egypt

Egypt Whole Genome Sequencing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Egypt Whole Genome Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Egypt · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $9.5 Mn Placeholder estimate
Estimate 2025 $11.3 Mn 0.3% of the global market
Projected 2034 $57.1 Mn 404.5% Adds $45.8 Mn over 9 forecast years
CAGR 2025–2034 19.7% Faster than 83% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Egypt is 0.33% of the global market.
  • In Africa, the largest is South Africa at $24.6 Mn.
  • Fastest growing: Egypt (this report) at 19.7% a year.
  • Egypt ranks 2nd of 3 by size in Africa.

Market size projection

Egypt

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$45.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Whole Genome Sequencing Market market size by year, Egypt
YearMarket sizeChange that yearSince 2025
2024 (estimate) $9.5 Mn — —
2025 (base) $11.3 Mn +$1.9 Mn —
2026 (forecast) $13.5 Mn +$2.2 Mn +19.7%
2027 (forecast) $16.2 Mn +$2.7 Mn +43.3%
2028 (forecast) $19.4 Mn +$3.2 Mn +71.5%
2029 (forecast) $23.2 Mn +$3.8 Mn +105.3%
2030 (forecast) $27.8 Mn +$4.6 Mn +145.7%
2031 (forecast) $33.3 Mn +$5.5 Mn +194.1%
2032 (forecast) $39.9 Mn +$6.6 Mn +252.1%
2033 (forecast) $47.7 Mn +$7.9 Mn +321.5%
2034 (forecast) $57.1 Mn +$9.4 Mn +404.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.48 Bn
  2. North America $1.76 Bn
  3. US $1.36 Bn
  4. APAC $684.4 Mn
  5. Europe $610.8 Mn
  6. Canada $299.6 Mn
  7. China $251.0 Mn
  8. Japan $238.8 Mn
  9. Germany $138.0 Mn
  10. Latin America $138.5 Mn
  11. Middle East $132.8 Mn
  12. Italy $92.0 Mn
  13. Brazil $89.7 Mn
  14. UK $83.4 Mn
  15. France $80.1 Mn
  16. Ecuador $67.2 Mn
  17. India $68.6 Mn
  18. Spain $63.3 Mn
  19. Saudi Arabia $60.8 Mn
  20. Mexico $50.7 Mn
  21. Africa $49.8 Mn
  22. New Zealand $39.2 Mn
  23. Russia $38.5 Mn
  24. Australia $38.9 Mn
  25. South Africa $24.6 Mn
  26. UAE $15.7 Mn
  27. Egypt (this report) $11.3 Mn
  28. Philippines $7.9 Mn
  29. Hong Kong $6.2 Mn
  30. Malaysia $5.5 Mn
  31. Thailand $4.5 Mn
  32. Singapore $4.1 Mn
  33. Kenya $2.1 Mn

Report snapshot

Egypt Whole Genome Sequencing Market Analysis at a glance
Market size, 2025$11.3 Mn placeholder estimate
Forecast, 2034$57.1 Mn placeholder estimate
Growth (CAGR), 2025–203419.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersIllumina, Inc., MGI Tech, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences (see all)
Regulator in EgyptEDASource: Egyptian Drug Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Egypt Whole Genome Sequencing Market Analysis Executive Summary

Whole genome sequencing reads a person's entire DNA code, used for rare disease diagnosis, cancer, research and population health.

Key segments of the whole Genome Sequencing market include product (Instruments, Consumables and Services) and application (Rare Disease Diagnosis, Oncology and Population Genomics).

Bar chart: Egypt Whole Genome Sequencing market size, 2024–2034, placeholder estimates. $9.5 Mn in 2024, $11.3 Mn in 2025 and $57.1 Mn in 2034, 19.7% CAGR.
Egypt Whole Genome Sequencing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Egypt Whole Genome Sequencing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the whole Genome Sequencing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the whole Genome Sequencing market.

Competitive Landscape for Whole Genome Sequencing Market in Egypt

The whole Genome Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Whole Genome Sequencing Market in Egypt

Whole Genome Sequencing in Egypt: rules and payment

Medicines are registered with the Egyptian Drug Authority (EDA), set up in 2019.⁠[1] A universal health insurance system, set up by Law No. 2 of 2018, is being rolled out governorate by governorate, starting with Port Said in 2019.⁠[2]

[1] Egyptian Drug Authority. Checked 14 Nov 2026.

[2] Universal Health Insurance Authority. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for whole Genome Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Egypt.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Whole Genome Sequencing right now, from free public sources.

Latest research 29,479 papers since 2021 (worldwide)

  1. Genomic profiling of maternal Streptococcus agalactiae reveals prophage-associated resistance and comparative characterization of anovaginal and respiratory isolates. Microbial pathogenesis, 2026
  2. Prevalence of new and repurposed drug resistance and associated genetic variants among rifampicin-resistant Mycobacterium tuberculosis in Shenzhen, China: a population-based study. International journal of antimicrobial agents, 2026
  3. Genomic Insights into Early Catheter-Associated UTIs in a Clinical Setting: High-Risk Clones, Hidden Diversity and Limited Catheter-Urine Genomic Divergence. The Journal of hospital infection, 2026
  4. Genomic and phenotypic characterization of four foodborne Vibrio harveyi: Insights into antimicrobial resistance, secretion systems, and ecological fitness. International journal of food microbiology, 2026
  5. The hidden burden of structural variants in neurodegenerative and neuromuscular disorders. Scientific reports, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Whole Genome Sequencing in context

Egypt compared

  • Health spending per person: 141 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 17 countries we cover in Africa.[1]
  • Doctors: 0.67 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 3rd highest of the 17 countries we cover in Africa.[2]
  • People aged 65 and over: 5.3% of people (2025). World: 10.4% of people (2025). 3rd highest of the 17 countries we cover in Africa.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Whole Genome Sequencing market in Egypt?
Placeholder estimate: about $11.3 Mn in 2025, rising to about $57.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Whole Genome Sequencing market in Egypt growing?
Placeholder estimate: about 19.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Whole Genome Sequencing market report cover?
The report splits the market by product (Instruments, Consumables, Services, Data Analysis), application (Rare Disease Diagnosis, Oncology, Population Genomics, Research) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Whole Genome Sequencing market?
Key players include Illumina, Inc., MGI Tech, Pacific Biosciences, Oxford Nanopore Technologies and Element Biosciences.
What is driving the Whole Genome Sequencing market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.
Who regulates Whole Genome Sequencing in Egypt?
Medicines are registered with the Egyptian Drug Authority (EDA), set up in 2019. Source: Egyptian Drug Authority. Checked 14 Nov 2026.
How is healthcare paid for in Egypt?
A universal health insurance system, set up by Law No. 2 of 2018, is being rolled out governorate by governorate, starting with Port Said in 2019. Source: Universal Health Insurance Authority. Checked 14 Nov 2026.
How much research is published on Whole Genome Sequencing?
PubMed lists 29,479 papers on Whole Genome Sequencing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Whole Genome Sequencing in Egypt? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Egypt

See all
Same topic, other categories

Related on genomics

See the topic